electroCore Q3 2023 revenue $4.5M (+128% YoY); raises FY23 guidance to $15-15.5M

electroCore, Inc.

2023-Q3 EPS reported -$2.87 revenue$10,839,000

Record Q3 net sales of $4.5M, a 128% increase from $2.0M in Q3 2022.
VA/DoD prescription revenue grew 135% YoY to $2.7M; US commercial up 12%.
GAAP net loss narrowed to $4.0M from $5.5M; adjusted EBITDA loss $3.0M from $4.8M.
Full-year 2023 revenue guidance raised to $15.0-15.5M (prior $14-15M).
Cash, equivalents & restricted cash $13.7M at Sept 30; raised $7.5M net in July offering.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

electroCore, Inc. reported year ending December 31, 2023 results: revenue $15.0 million - $15.5 million. Guidance raised.

Period: year ending December 31, 2023
Revenue: $15.0 million - $15.5 million
Guidance: raised
Result: guidance update

Exact text from the filing

The Company is increasing its revenue guidance for the year ending December 31, 2023 to be $15.0 million - $15.5 million, as compared to its previous guidance of $14.0 million - $15.0 million.

View on SEC.gov

Browse all earnings releases →

electroCore, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-23-084755

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.